Neuron-associated macrophage proliferation in the sensory ganglia is associated with peripheral nerve injury-induced neuropathic pain involving CX3CR1 signaling

Abstract

Resident macrophages are distributed across all tissues and are highly heterogeneous due to adaptation to different tissue-specific environments. The resident macrophages of the sensory ganglia (sensory neuron-associated macrophages, sNAMs) are in close contact with the cell body of primary sensory neurons and might play physiological and pathophysiological roles. After peripheral nerve injury, there is an increase in the population of macrophage in the sensory ganglia, which have been implicated in different conditions, including neuropathic pain development. However, it is still under debate whether macrophage accumulation in the sensory ganglia after peripheral nerve injury is due to the local proliferation of resident macrophages or a result of blood monocyte infiltration. Here, we confirmed that the number of macrophages increased in the sensory ganglia after the spared nerve injury (SNI) model in mice. Using different approaches, we found that the increase in the number of macrophages in the sensory ganglia after SNI is a consequence of the proliferation of resident CX3CR1+ macrophages, which participate in the development of neuropathic pain, but not due to infiltration of peripheral blood monocytes. These proliferating macrophages are the source of pro-inflammatory cytokines such as TNF and IL-1b. In addition, we found that CX3CR1 signaling is involved in the sNAMs proliferation and neuropathic pain development after peripheral nerve injury. In summary, these results indicated that peripheral nerve injury leads to sNAMs proliferation in the sensory ganglia in a CX3CR1-dependent manner accounting for neuropathic pain development. In conclusion, sNAMs proliferation could be modulated to change pathophysiological conditions such as chronic neuropathic pain.

Data availability

All data generated or analyzed during this study are included in the manuscript. Public scRNA-seq data are available in Gene Expression Omnibus (GEO) database under the series number GSE139103 (Avraham et al. 2020).

The following previously published data sets were used

Article and author information

Author details

  1. Rafaela Mano Guimarães

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  2. Conceição Elidianne Aníbal-Silva

    Department of Pharmacology, University of Sao Paulo, Ribeirão Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  3. Marcela Davoli-Ferreira

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  4. Francisco Isaac Fernandes Gomes

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  5. Atlante Silva Mendes

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  6. Maria Claudia Magalhães Cavallini

    Department of Pharmacology, University of Sao Paulo, Ribeirão Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  7. Miriam Mendes Fonseca

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  8. Samara Damasceno

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  9. Larissa Pinto Andrade

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  10. Marco Colonna

    Department of Pathology and Immunology, Washington University in St. Louis, Saint Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Cyril Rivat

    Institut des Neurosciences de Montpellier, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Fernando Q Cunha

    Department of Pharmacology, University of Sao Paulo, Ribeirão Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  13. José C Alves-Filho

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  14. Thiago Mattar Cunha

    Department of Pharmacology, University of Sao Paulo, Ribeirao Preto, Brazil
    For correspondence
    thicunha@fmrp.usp.br
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1084-0065

Funding

The authors declare that there was no funding for this work.

Ethics

Animal experimentation: Animal care and handling procedures were under the guidelines of the International Association for the Study of Pain for those animals used in pain research and were approved by the Committee for Ethics in Animal Research of the Ribeirao Preto Medical School- University of São Paulo (Process number 002/2017).

Copyright

© 2023, Guimarães et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,629
    views
  • 443
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rafaela Mano Guimarães
  2. Conceição Elidianne Aníbal-Silva
  3. Marcela Davoli-Ferreira
  4. Francisco Isaac Fernandes Gomes
  5. Atlante Silva Mendes
  6. Maria Claudia Magalhães Cavallini
  7. Miriam Mendes Fonseca
  8. Samara Damasceno
  9. Larissa Pinto Andrade
  10. Marco Colonna
  11. Cyril Rivat
  12. Fernando Q Cunha
  13. José C Alves-Filho
  14. Thiago Mattar Cunha
(2023)
Neuron-associated macrophage proliferation in the sensory ganglia is associated with peripheral nerve injury-induced neuropathic pain involving CX3CR1 signaling
eLife 12:e78515.
https://doi.org/10.7554/eLife.78515

Share this article

https://doi.org/10.7554/eLife.78515

Further reading

    1. Immunology and Inflammation
    Josep Garnica, Patricia Sole ... Pere Santamaria
    Research Article

    Chronic antigenic stimulation can trigger the formation of interleukin 10 (IL-10)-producing T-regulatory type 1 (TR1) cells in vivo. We have recently shown that murine T-follicular helper (TFH) cells are precursors of TR1 cells and that the TFH-to-TR1 cell transdifferentiation process is characterized by the progressive loss and acquisition of opposing transcription factor gene expression programs that evolve through at least one transitional cell stage. Here, we use a broad range of bulk and single-cell transcriptional and epigenetic tools to investigate the epigenetic underpinnings of this process. At the single-cell level, the TFH-to-TR1 cell transition is accompanied by both, downregulation of TFH cell-specific gene expression due to loss of chromatin accessibility, and upregulation of TR1 cell-specific genes linked to chromatin regions that remain accessible throughout the transdifferentiation process, with minimal generation of new open chromatin regions. By interrogating the epigenetic status of accessible TR1 genes on purified TFH and conventional T-cells, we find that most of these genes, including Il10, are already poised for expression at the TFH cell stage. Whereas these genes are closed and hypermethylated in Tconv cells, they are accessible, hypomethylated, and enriched for H3K27ac-marked and hypomethylated active enhancers in TFH cells. These enhancers are enriched for binding sites for the TFH and TR1-associated transcription factors TOX-2, IRF4, and c-MAF. Together, these data suggest that the TR1 gene expression program is genetically imprinted at the TFH cell stage.

    1. Genetics and Genomics
    2. Immunology and Inflammation
    Stephanie Guillet, Tomi Lazarov ... Frédéric Geissmann
    Research Article

    Systemic lupus erythematosus (SLE) is an autoimmune disease, the pathophysiology and genetic basis of which are incompletely understood. Using a forward genetic screen in multiplex families with SLE, we identified an association between SLE and compound heterozygous deleterious variants in the non-receptor tyrosine kinases (NRTKs) ACK1 and BRK. Experimental blockade of ACK1 or BRK increased circulating autoantibodies in vivo in mice and exacerbated glomerular IgG deposits in an SLE mouse model. Mechanistically, NRTKs regulate activation, migration, and proliferation of immune cells. We found that the patients’ ACK1 and BRK variants impair efferocytosis, the MERTK-mediated anti-inflammatory response to apoptotic cells, in human induced pluripotent stem cell (hiPSC)-derived macrophages, which may contribute to SLE pathogenesis. Overall, our data suggest that ACK1 and BRK deficiencies are associated with human SLE and impair efferocytosis in macrophages.